We at the DAS Law Group, P.A., medical device recall team have been monitoring hip replacement recalls for product defects.
We have had several of these claims successfully concluded for our clients, with them receiving compensation for medical bills and pain and suffering.
On May 22, 2018, Stryker Orthopedics updated its LFIT V40 femoral head recall to include eight additional catalog numbers. The original recall occurred in August 2016 and included seven catalog numbers, which represented close to 45,000 devices in commerce.
The LFIT V40 is a femoral head used in hip replacement surgeries. According to the recall, Stryker has received a higher than expected number of femoral head/hip stem dissociations. Severe complications from the LFIT V40 head include:
The Stryker LFIT V40 is designed to offer a broad range of offsets based on the patients’ needs and can be used interchangeably with Stryker’s entire product line of modular total hip arthroplasty devices. Unfortunately, due to potential corrosion at the head-neck junction, catastrophic dissociation and metallosis can occur and require emergent revision surgery.
The unsafe drug and medical device team at DAS Law Group, P.A. is investigating the Stryker LFIT CoCr V40 femoral head cases on behalf of patients who were implanted with these devices and have suffered complications. If you receive any calls regarding these products, we welcome the opportunity to work with you and your clients.
Call Della Stafford, team leader for the DAS Law Group, P.A., medical device team, at 704-377-5242 or email [email protected].
"*" indicates required fields